Fundraising Fox

Delpharm

Orléans, FR · 1 known investors

Delpharm is a contract development and manufacturing organization (CDMO) that develops and manufactures pharmaceutical products for the pharmaceutical industry across solid, sterile, semi-solid, and liquid dosage forms. With manufacturing sites across Europe and North America, the company ranks among the top 5 global CDMOs and specializes in pre-filled syringes, nasal sprays, and liquid pharmaceuticals.

Advanced ManufacturingBiotechEnterprise Software

Investors · 1

Andera PartnersParis

Competitors · 1

by search overlap
Medpharm21 shared keywordsMedPharm is a contract development and manufacturing organization (CDMO) focused on topical, transdermal, and transepithelial drug products, supporting formulation development, in vitro testing, and GMP manufacturing from early development through commercial supply. It serves pharmaceutical and biotechnology companies, with facilities in Guildford, UK, and Durham, North Carolina, USA.

Companies competing with Delpharm for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Delpharm Set to Transform Boucherville Facility After Securing Government Funding — The Pharma Navigator - Navigating The Key News Stories In Pharmathepharmanavigator.com · Sep 2025Delpharm Gains $60M Quebec Support for Expansion of Boucherville Operations - PharmaSourcepharmasource.global · Sep 2025Quebec invests $60 million in Delpharm Boucherville pharmaceutical plantctvnews.ca · Aug 2025Delpharm Secures USD 42 Mn Investment to Upgrade Injectables Plant — The Pharma Navigator - Navigating The Key News Stories In Pharmathepharmanavigator.com · Apr 2025Delpharm Gets $60M Federal Investment to Modernize its Manufacturing Facilitymanufacturing-today.com · Mar 2025Delpharm plans $140m investment to upgrade Boucherville facilitypharmaceutical-business-review.com · Mar 2025

Frequently asked questions

What does Delpharm do?
Delpharm is a contract development and manufacturing organization (CDMO) that develops and manufactures pharmaceutical products for the pharmaceutical industry across solid, sterile, semi-solid, and liquid dosage forms. With manufacturing sites across Europe and North America, the company ranks among the top 5 global CDMOs and specializes in pre-filled syringes, nasal sprays, and liquid pharmaceuticals.
Who are Delpharm's investors?
Delpharm's investors include Andera Partners.
Where is Delpharm headquartered?
Delpharm is headquartered in Orléans, FR.